EMERALD THERAPEUTICS Trademark

Trademark Overview

On Monday, October 11, 2021, a trademark application was filed for EMERALD THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the EMERALD THERAPEUTICS trademark a serial number of 97068643. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Thursday, October 3, 2024. This trademark is owned by Emerald Therapeutics, Inc.. The EMERALD THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations used to treat viral infections; pharmaceutical preparations, namely, nucleic acids for therapeutic use; pharmaceutical preparations used to detect and regulate target polynucleotides
emerald therapeutics

General Information

Serial Number97068643
Word MarkEMERALD THERAPEUTICS
Filing DateMonday, October 11, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateThursday, October 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 23, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations used to treat viral infections; pharmaceutical preparations, namely, nucleic acids for therapeutic use; pharmaceutical preparations used to detect and regulate target polynucleotides
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 2, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEmerald Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameEmerald Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Thursday, October 14, 2021NEW APPLICATION ENTERED
Tuesday, November 2, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 14, 2022ASSIGNED TO EXAMINER
Thursday, July 14, 2022NON-FINAL ACTION WRITTEN
Thursday, July 14, 2022NON-FINAL ACTION E-MAILED
Friday, July 15, 2022EXAMINERS AMENDMENT -WRITTEN
Thursday, July 14, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 15, 2022EXAMINERS AMENDMENT E-MAILED
Friday, July 15, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, July 15, 2022EXAMINER'S AMENDMENT ENTERED
Friday, July 15, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 3, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 23, 2022PUBLISHED FOR OPPOSITION
Tuesday, August 23, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 18, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 17, 2023SOU TEAS EXTENSION RECEIVED
Monday, April 17, 2023SOU EXTENSION 1 FILED
Monday, April 17, 2023SOU EXTENSION 1 GRANTED
Wednesday, April 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 4, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, October 4, 2023SOU EXTENSION 2 FILED
Wednesday, October 4, 2023SOU EXTENSION 2 GRANTED
Friday, October 6, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 18, 2024SOU TEAS EXTENSION RECEIVED
Thursday, April 18, 2024SOU EXTENSION 3 FILED
Thursday, April 18, 2024SOU EXTENSION 3 GRANTED
Friday, April 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 3, 2024SOU TEAS EXTENSION RECEIVED
Thursday, October 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 3, 2024SOU EXTENSION 4 GRANTED
Thursday, October 3, 2024SOU EXTENSION 4 FILED
Tuesday, April 15, 2025SOU TEAS EXTENSION RECEIVED

Related Keywords

therapeutics emerald preparations pharmaceutical used regulate detect polynucleotides therapeutic target namely treat